Your browser doesn't support javascript.
loading
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Ingham, Matthew; Allred, Jacob B; Chen, Li; Das, Biswasjit; Kochupurakkal, Bose; Gano, Katherine; George, Suzanne; Attia, Steven; Burgess, Melissa A; Seetharam, Mahesh; Boikos, Sosipatros A; Bui, Nam; Chen, James L; Close, Julia L; Cote, Gregory M; Thaker, Premal H; Ivy, S Percy; Bose, Sminu; D'Andrea, Alan; Marino-Enriquez, Adrian; Shapiro, Geoffrey I; Schwartz, Gary K.
Afiliación
  • Ingham M; Columbia University Irving Medical Center, New York, NY.
  • Allred JB; Mayo Clinic, Rochester, MN.
  • Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Das B; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Kochupurakkal B; Center for DNA Damage Repair, Dana-Farber Cancer Institute, Boston, MA.
  • Gano K; Mayo Clinic, Rochester, MN.
  • George S; Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA.
  • Attia S; Mayo Clinic, Jacksonville, FL.
  • Burgess MA; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA.
  • Seetharam M; Mayo Clinic Arizona, Scottsdale, AZ.
  • Boikos SA; Washington Hospital Center, Washington, DC.
  • Bui N; Stanford University, Stanford, CA.
  • Chen JL; The Ohio State University, Columbus, OH.
  • Close JL; University of Florida/UF Health Cancer Center, Gainesville, FL.
  • Cote GM; Massachusetts General Hospital, Boston, MA.
  • Thaker PH; Washington University School of Medicine, St Louis, MO.
  • Ivy SP; National Cancer Institute, Rockville, MD.
  • Bose S; Columbia University Irving Medical Center, New York, NY.
  • D'Andrea A; Center for DNA Damage Repair, Dana-Farber Cancer Institute, Boston, MA.
  • Marino-Enriquez A; Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA.
  • Shapiro GI; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Schwartz GK; Center for DNA Damage Repair, Dana-Farber Cancer Institute, Boston, MA.
J Clin Oncol ; 41(25): 4154-4163, 2023 09 01.
Article en En | MEDLINE | ID: mdl-37467452
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Leiomiosarcoma Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Leiomiosarcoma Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos